Search

Your search keyword '"Floto RA"' showing total 126 results

Search Constraints

Start Over You searched for: Author "Floto RA" Remove constraint Author: "Floto RA"
126 results on '"Floto RA"'

Search Results

1. Body Mass Index and Nutritional Intake following Elexacaftor/Tezacaftor/Ivacaftor Modulator Therapy in Adults with Cystic Fibrosis

2. Microbiological evaluation of UV disinfection effectiveness in a specialist cystic fibrosis clinic

3. Germline selection shapes human mitochondrial DNA diversity

4. British Thoracic Society guideline for bronchiectasis in adults (BMJ Open)

5. M26 Convergent validity of bronchiectasis quality of life tools in the BRONCH-UK registry

6. M27 Bronchiectasis multicentre cohort; baseline demographics from BRONCHUK

7. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy

8. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

11. Distinct cell-specific control of autoimmunity and infection by Fc gamma RIIb

15. IFN-γ and dibutyryl cAMP pre-treatment of U937 cells results in different Ca2+ signals triggered by antibody cross-linking of the human high affinity receptor for IgG (FcγRI)

16. Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

17. A Rapid Unraveling of the Activity and Antibiotic Susceptibility of Mycobacteria

19. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

20. Microbial metabolism disrupts cytokine activity to impact host immune response.

21. Global genomic surveillance of monkeypox virus.

22. A Fragment-Based Competitive 19 F LB-NMR Platform For Hotspot-Directed Ligand Profiling.

23. Evolution and host-specific adaptation of Pseudomonas aeruginosa .

24. In vitro platform to model the function of ionocytes in the human airway epithelium.

25. Unlocking Amides: A General Method for the Self-Immolative Release of Amide-Containing Molecules.

26. Lipoarabinomannan modification as a source of phenotypic heterogeneity in host-adapted Mycobacterium abscessus isolates.

27. Clinically relevant mutations in the PhoR sensor kinase of host-adapted Mycobacterium abscessus isolates impact response to acidic pH and virulence.

28. Mutational spectra are associated with bacterial niche.

29. Body mass index and nutritional intake following Elexacaftor/Tezacaftor/Ivacaftor modulator therapy in adults with cystic fibrosis.

30. Impact of a new hospital with close to 100% single-occupancy rooms on environmental contamination and incidence of vancomycin-resistant Enterococcus faecium colonization or infection: a genomic surveillance study.

31. Butyrate regulates neutrophil homeostasis and impairs early antimicrobial activity in the lung.

32. Evaluating Listening Performance for COVID-19 Detection by Clinicians and Machine Learning: Comparative Study.

33. Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review.

34. A lung-specific mutational signature enables inference of viral and bacterial respiratory niche.

35. Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis.

36. Development and validation of a CRISPR interference system for gene regulation in Campylobacter jejuni.

37. The Removal of Airborne Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Microbial Bioaerosols by Air Filtration on Coronavirus Disease 2019 (COVID-19) Surge Units.

38. Exploring Longitudinal Cough, Breath, and Voice Data for COVID-19 Progression Prediction via Sequential Deep Learning: Model Development and Validation.

39. Structural Characterization of Mycobacterium abscessus Phosphopantetheine Adenylyl Transferase Ligand Interactions: Implications for Fragment-Based Drug Design.

40. Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responses.

41. Roscovitine Worsens Mycobacterium abscessus Infection by Reducing DUOX2-mediated Neutrophil Response.

42. Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis.

43. Antibiotic Management in Bronchiectasis.

44. Development of Inhibitors of SAICAR Synthetase (PurC) from Mycobacterium abscessus Using a Fragment-Based Approach.

45. Discovery of Novel Inhibitors of Uridine Diphosphate- N -Acetylenolpyruvylglucosamine Reductase (MurB) from Pseudomonas aeruginosa , an Opportunistic Infectious Agent Causing Death in Cystic Fibrosis Patients.

46. RNA Sequencing Elucidates Drug-Specific Mechanisms of Antibiotic Tolerance and Resistance in Mycobacterium abscessus.

47. Dissemination of Mycobacterium abscessus via global transmission networks.

48. Integrated human/SARS-CoV-2 metabolic models present novel treatment strategies against COVID-19.

49. Increased Virulence of Outer Membrane Porin Mutants of Mycobacterium abscessus .

50. Stepwise pathogenic evolution of Mycobacterium abscessus .

Catalog

Books, media, physical & digital resources